References
- Drueke TB. Cell biology of parathyroid gland hyperplasia in chronic renal failure. J Am Soc Nephrol 2000;11:1141-52
- Fukagawa M, Nakanishi S, Kazama JJ. Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease. Kidney Int 2006;70(102 Suppl):S3-7
- Joy MS, Karagiannis PC, Peyerl FW. Outcomes of secondary hyperparathyroidism in chronic kidney disease and the direct costs of treatment. J Manag Care Pharm 2007;13:397-411
- Drueke TB, Ritz E. Treatment of secondary hyperparathyroidism in CKD patients with cinacalcet and/or vitamin D derivatives. Clin J Am Soc Nephrol 2009;4:234-41
- Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int 2004;66:2010-16
- Kestenbaum B, Seliger SL, Gillen DL, et al. Parathyroidectomy rates among United States dialysis patients: 1990-1999. Kidney Int 2004;65:282-8
- The British Association of Endocrine and Thyroid Surgeons. Fourth National Audit Report. Henley-on-Thames: Dendrite Clinical Systems Ltd, 2012
- Department of Health. Payment by Results National Tariffs 2011–2012. http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_125398.xls. Accessed April 2013
- Department of Health. NHS Reference Costs 2011–12. https://www.gov.uk/government/publications/nhs-reference-costs-financial-year-2011-to-2012. Accessed April 2013
- Fotheringham J, Duenas A, Rawdin A, et al. Assessing the cost of parathyroidectomy as a treatment for uncontrolled secondary hyperparathyroidism in stage 5 chronic kidney disease. Poster presented at ERA- EDTA congress in Munich: June, 2010
- Baboolal K, McEwan P, Sondhi S, et al. The cost of renal dialysis in a UK setting–a multicentre study. Nephrol Dial Transplant 2008;23:1982-9
- Office of National Statistics (ONS). 2010-Based National Population Projections. http://www.ons.gov.uk/ons/rel/npp/national-population-projections/2010-based-projections/rep-2010-based-npp-results-summary.html#tab-Results. Accessed March 2013
- Office of National Statistics (ONS). Consumer Price Indices available from the Office of National Statistics. http://www.ons.gov.uk/ons/rel/cpi/consumer-price-indices/index.html. Accessed March 2013
- NHS Information Centre. HRG4 2010/11 Reference Costs Grouper Documentation HRG4 2010/11 Reference Costs Grouper Chapter Listings
- Curtis. Unit Costs of Health and Social Care 2011. University of Kent. http://www.pssru.ac.uk/archive/pdf/uc/uc2011/uc2011.pdf. Accessed March 2013
- Garside R, Pitt M, Anderson R, et al. The effectiveness and cost-effectiveness of cinacalcet for secondary hyperparathyroidism in end-stage renal disease patients on dialysis: a systematic review and economic evaluation. Health Technol Assess 2007;11(18):iii, xi-xiii, 1-167
- Kidney Care. Developing robust reference costs for kidney transplants Update. 2011. http://www.kidneycare.nhs.uk/Library/DevelopingRobustreferencereportWEBFINAL.pdf. Accessed April 2012
- Joint Formulary Committee. British National Formulary (online). 2012. London: BMJ Group and Pharmaceutical Press, http://www.medicinescomplete.com. Accessed April 2012
- Pruthi R, Pitcher D, Dawnay A. UK Renal Registry 14th Annual Report: Chapter 9 Biochemical variables amongst UK adult dialysis patients in 2010: National and centre-specific analyses. 2011. http://www.renalreg.com/Reports/2011.html. Accessed October 2013